Form 4 Filing for Patel Samir Rashmikant

This filing details transactions by Patel Samir Rashmikant, a director at Akari Therapeutics Plc. On August 18, 2026, Mr. Patel acquired 6,300 American Depositary Shares (ADSs) representing ordinary shares, with a footnote indicating these were part of restricted stock units (RSUs) granted in lieu of unpaid retainers and subject to shareholder approval for vesting. On the same date, he was granted options to purchase 30,000 ADSs and 15,000 ADSs, also contingent on shareholder approval for vesting. On October 5, 2026, an additional 2,236 ADSs were acquired, again noted as RSUs subject to shareholder approval. All transactions had a price per share of $7.899, except for the options which had a price of $0.0. The post-transaction holdings reported are 9,866 shares after the August 18th acquisition and 12,102 shares after the October 5th acquisition.